Insider · CIK 0001253979
Randolph L Marten
Files at MRTN (MARTEN TRANSPORT LTD). First filing -, latest -.
Randolph L Marten files SEC Form 4 as chair, director, 10% owner and CEO at MRTN (MARTEN TRANSPORT LTD). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Randolph L Marten has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 5, 2026 | MRTN MARTEN TRANSPORT LTD | AGrant or award Common Stock | +12,300 | $0.00 | $0 | 17,744,100 | May 7, 2026 |
| Feb 20, 2026 | MRTN MARTEN TRANSPORT LTD | FTax withholding Common Stock | -4,657 | $13.90 | $65k | 17,731,800 | Feb 23, 2026 |
| Aug 19, 2025 | MRTN MARTEN TRANSPORT LTD | GGift Common Stock | -1,500 | $0.00 | $0 | 17,736,457 | Aug 19, 2025 |
| May 6, 2025 | MRTN MARTEN TRANSPORT LTD | AGrant or award Common Stock | +13,515 | $0.00 | $0 | 17,737,957 | May 8, 2025 |
Questions about Randolph L Marten
Answered from the filings on this page, as of the latest one.
Is Randolph L Marten buying or selling?
Randolph L Marten has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Randolph L Marten's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Randolph L Marten has 0.
Where does Randolph L Marten file Form 4?
Randolph L Marten has filed Form 4 at MRTN (MARTEN TRANSPORT LTD) as Chairman of the Board and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.